Safe and Affordable Drugs from Canada Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Mar 9, 2017)
Safe and Affordable Drugs from Canada Act of 2017
This bill amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to require the Department of Health and Human Services (HHS) to promulgate regulations within 180 days permitting individuals to import a prescription drug purchased from an approved Canadian pharmacy that:
- is dispensed by a pharmacist licensed in Canada;
- is purchased for personal use in quantities not greater than a 90-day supply;
- is filled using a valid prescription issued by a physician licensed to practice in the United States; and
- has the same active ingredients, route of administration, dosage form, and strength as a prescription drug approved under the FFDCA.
Certain medications may not be imported, including controlled substances and biological products.
The bill establishes a certification process for approving Canadian pharmacies. HHS must publish a list of approved Canadian pharmacies.
What just happenedMar 10, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseMar 9, 2017
- Mar 10, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 9, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 9, 2017IntroReferralIntro-H
Introduced in House
- Mar 9, 2017IntroReferral1000
Introduced in House